These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 25883214)

  • 1. Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.
    Gangoda L; Keerthikumar S; Fonseka P; Edgington LE; Ang CS; Ozcitti C; Bogyo M; Parker BS; Mathivanan S
    Oncotarget; 2015 May; 6(13):11175-90. PubMed ID: 25883214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: implications of intra-tumour heterogeneity.
    Fonseka P; Liem M; Ozcitti C; Adda CG; Ang CS; Mathivanan S
    J Extracell Vesicles; 2019; 8(1):1597614. PubMed ID: 31007876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death.
    Sagulenko V; Muth D; Sagulenko E; Paffhausen T; Schwab M; Westermann F
    Carcinogenesis; 2008 Oct; 29(10):1869-77. PubMed ID: 18566016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase.
    Veas-Perez de Tudela M; Delgado-Esteban M; Cuende J; Bolaños JP; Almeida A
    J Neurochem; 2010 May; 113(4):819-25. PubMed ID: 20180881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
    Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
    Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells.
    Ushmorov A; Hogarty MD; Liu X; Knauss H; Debatin KM; Beltinger C
    Oncogene; 2008 May; 27(24):3424-34. PubMed ID: 18193081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics.
    Zheng X; Naiditch J; Czurylo M; Jie C; Lautz T; Clark S; Jafari N; Qiu Y; Chu F; Madonna MB
    Cell Death Dis; 2013 Jul; 4(7):e740. PubMed ID: 23887631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Myc knockdown and apigenin treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification.
    Hossain MM; Banik NL; Ray SK
    Gene; 2013 Oct; 529(1):27-36. PubMed ID: 23941992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
    Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; Raschellà G; Dominici C
    Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
    Liu HJ; Li GL; Lei PC
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA-damaging drug-induced apoptosis sensitized by N-myc in neuroblastoma cells.
    Li T; Wang L; Ke XX; Gong XY; Wan JH; Hao XW; Xu M; Xiang Z; Cui ZB; Cui H
    Cell Biol Int; 2012 Apr; 36(4):331-7. PubMed ID: 21929510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
    Hossain MM; Banik NL; Ray SK
    Exp Cell Res; 2012 Aug; 318(13):1597-610. PubMed ID: 22507272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemether Regulates Chemosensitivity to Doxorubicin via Regulation of B7-H3 in Human Neuroblastoma Cells.
    Tan WQ; Chen G; Ye M; Jia B
    Med Sci Monit; 2017 Sep; 23():4252-4259. PubMed ID: 28866709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-MYC regulates focal adhesion kinase expression in human neuroblastoma.
    Beierle EA; Trujillo A; Nagaram A; Kurenova EV; Finch R; Ma X; Vella J; Cance WG; Golubovskaya VM
    J Biol Chem; 2007 Apr; 282(17):12503-16. PubMed ID: 17327229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
    Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
    Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.
    Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ
    Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of therapy targeted genes expression in neuroblastoma cell lines].
    Lebedev TD; Spirin PV; Orlova NN; Prokofjeva MM; Prassolov VS
    Mol Biol (Mosk); 2015; 49(6):1048-51. PubMed ID: 26710789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells.
    Noujaim D; van Golen CM; van Golen KL; Grauman A; Feldman EL
    Oncogene; 2002 Jul; 21(29):4549-57. PubMed ID: 12085233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
    Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line.
    Vangipuram SD; Buck SA; Lyman WD
    Tumour Biol; 2012 Dec; 33(6):2173-83. PubMed ID: 22886526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.